$78.53
+5.53 (+7.58%)
Performance
1D
—
1W
—
1M
—
3M
+1.56%
6M
+97.16%
1Y
+95.64%
YTD
+3.63%
Open$74.59
Previous Close$73.00
Day High$85.04
Day Low$73.98
52W High$84.56
52W Low$26.20
Volume—
Avg Volume883.8K
Market Cap5.05B
P/E Ratio—
EPS$-4.36
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$73.88
Above
SMA 200
$52.13
Above
RSI (14)
48.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+29.3% upside
Current
$78.53
$78.53
Target
$101.57
$101.57
$78.76
$101.57 avg
$153.22
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 911.35M | 871.62M | 948.06M |
| Net Income | -243,438,723 | -174,175,180 | -203,637,440 |
| Profit Margin | -26.7% | -20.0% | -21.5% |
| EBITDA | -267,934,128 | -228,786,100 | -261,593,713 |
| Free Cash Flow | -101,879,133 | -97,401,406 | -128,866,616 |
| Rev Growth | +22.2% | +5.3% | +12.3% |
| Debt/Equity | 0.88 | 0.85 | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |